Halobetasol propionate

CAS : 66852-54-8

Ref. 3D-FH23728

Informations sur le produit

• Nom: Halobetasol propionate
• Synonymes: (6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dioneMiracortenUlobetasol propiona te, (6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione, Bmy 30056, Cgp 14458, Miracorten, Ulobetasol propionate, Ultravate, ethyl (6alpha,11beta,16beta)-21-chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17-carboxylate, (6alpha,8xi,10xi,13xi,14xi,16beta)-21-chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate, 21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate, (6alpha,11beta,16beta)-21-chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate, Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6α,11β,16β)-

Description

Halobetasol propionate is a corticosteroid that is used to treat inflammatory skin diseases such as psoriasis and atopic dermatitis. It belongs to the group of drugs known as topical steroids, which are applied to the skin. Halobetasol propionate may also be used to treat choroidal neovascularization (CNV) or ocular hypertension in patients with age-related macular degeneration, but it is not approved for this use. The mechanism of action of halobetasol propionate is not fully understood, but it has been shown to inhibit the activity of certain proteins involved in inflammation. Halobetasol propionate has been shown to be more effective than hydrocortisone in reducing the severity and frequency of cutaneous lesions in patients with psoriasis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 484.96 g/mol
• Formule: C₂₅H₃₁ClF₂O₅
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder